DXR - Daxor Corporation

NYSE American - NYSE American Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue-551.42533.6191,047.986
Cost of Revenue----
Gross Profit-551.42533.6191,047.986
Operating Expenses
Research Development----
Selling General and Administrative-124.596304.873378.09
Non Recurring----
Others----
Total Operating Expenses-124.596304.873378.09
Operating Income or Loss-426.824228.746669.896
Income from Continuing Operations
Total Other Income/Expenses Net--1,642.11,238.63-8,550.571
Earnings Before Interest and Taxes-426.824228.746669.896
Interest Expense--72.974-37.329-160.646
Income Before Tax--1,215.2761,467.376-7,880.675
Income Tax Expense-24.61411.6131,265.675
Minority Interest----
Net Income From Continuing Ops--1,239.891,455.763-9,146.35
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income--1,239.891,455.763-9,146.35
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares--1,239.891,455.763-9,146.35